• Citer

Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triplenegative breast cancer

par Locatelli, Marzia Adelia;Shaik, Mahmood Naveed;Kern, Kenneth K.A.;Curigliano, Giuseppe;Aftimos, Philippe ;Claire Dees, E.;LoRusso, Patricia Mucci;Pegram, Mark;Awada, Ahmad ;Huang, Bo;Cesari, Rossano;Jiang, Yuqiu
Référence Oncotarget, 8, 2, page (2320-2328)
Publication Publié, 2017

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triplenegative breast cancer
Auteur:	Locatelli, Marzia Adelia; Shaik, Mahmood Naveed; Kern, Kenneth K.A.; Curigliano, Giuseppe; Aftimos, Philippe; Claire Dees, E.; LoRusso, Patricia Mucci; Pegram, Mark; Awada, Ahmad; Huang, Bo; Cesari, Rossano; Jiang, Yuqiu
Informations sur la publication:	Oncotarget, 8, 2, page (2320-2328)
Statut de publication:	Publié, 2017
Sujet CREF:	Psychiatrie
Mots-clés:	Breast cancer
	Gamma secretase
	NOTCH signaling
	PF-03084014
	Triple-negative
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1949-2553
	info:doi/10.18632/oncotarget.13727
	info:scp/85009798907